查詢結果分析
來源資料
相關文獻
- 探討以糖化血色素評估使用全靜脈營養患者血糖耐性之適用性
- Comparison of the Metabolic Effects of All-in-One and Conventional Total Parenteral Nutrition Infusions in Rats
- 小兒使用TPN引起的併發症
- 臺北榮民總醫院新陳代謝科門診糖尿病病患血糖控制狀況
- 持續性及循環性全靜脈營養方式對大白鼠身體組成及肝臟功能的改變
- 糖化血色素的臨床應用
- 利用PRIMUS Affinity HPLC與TOSOH Ion-Exchange HPLC檢測血液中Total GHb及HbA1c之比較
- 靜脈營養添加物及其安全性之探討
- 小兒全靜脈營養
- External Gastrointestinal Fistula After the Advent of Total Parental Nutrition
頁籤選單縮合
題 名 | 探討以糖化血色素評估使用全靜脈營養患者血糖耐性之適用性=Utility of HbA1c Levels for Impaired Glucose Tolerance Finding in Hospitalized Patients on Total Parental Nutritional Support |
---|---|
作 者 | 常傳訓; 林孟瑜; 黃幸妮; 殷秀妙; 周育如; 余璧如; 葉錦瑩; 張仙平; | 書刊名 | 中華民國營養學會雜誌 |
卷 期 | 30:1 民94.06 |
頁 次 | 頁36-42 |
分類號 | 416.351 |
關鍵詞 | 糖化血色素; 全靜脈營養; 耐糖障礙; HbA1c; Total prenatal nutrition; Impaired glucose tolerance; |
語 文 | 中文(Chinese) |
中文摘要 | 探討以糖化血色素(hemoglobin A1c,簡稱HbA1c)評估全靜脈營養(total parental nutrition, 簡稱TPN)患者之血糖耐受適用性,找出使用TPN易發生高血糖之危險族群,提早給予適宜血糖管理。蒐集振興復健醫學中心92年8月至12月之住院病患且無糖尿病病史者,使用TPN營養支持者共48人,登錄年齡、性別、身高、體重、疾病史等基本資料後,收集開始接受TPN輸液七天內之基本檢驗數據,並在第一天測量HbA1c值,且監測及記錄其血糖狀況直至停止接受TPN。利用ROC分析法找出適宜敏感度及特異度之HbA1c切點。本研究發現,針對未曾有過糖尿病診斷或病史者利用ROC分析法找出之HbA1c切點落於5.6%時,有最適宜的敏感性(70%)及特異性(84.2%)。由本研究結果推論,當病患接受TPN第一天測得HbA1c值大於5.6%時,可能因存有耐糖障礙的情況而增加接受TPN期間發生高血糖的機會,建議對於此族群病患給予積極的血糖監控,以期對疾病復原有所助益。不過,醫院內接受TPN支持者多屬於病情況複雜之重症病患,可能含有許多影響血糖之多重因素,實際應用與可行性仍有待未來深入探討。 |
英文摘要 | We evaluated the utility of hemoglobin A1c (HbA1c) levels for impaired glucose tolerance findings in hospitalized patients receiving total parental nutritional (TPN) support. From August 1(superscript st) to December 31(subscript st) 2003, there were 48 patients without diabetes history receiving TPN support at Cheng Hsin rehabilitation medical center hospital. We measured HbA1c levels on the first day and recorded other laboratory data (i.e., albumin and hemoglobin) for the next 7 days when patients were receiving TPN, and also measured blood sugar levels until the patient stopped the TPN therapy. A receiver operator characteristic (ROC) analysis was performed to assess the sensitivity and specificity of various HbA1c levels. The results revealed that HbA1c cut off of 5.6% gave the optimal sensitivity (70%) and specificity (84.2%) for patients without a diabetes history. Our data suggest that if the patient's HbA1c is greater than 5.6% on the first day of receiving TPN, that this may be a high-risk factor for hyperglycemia occurrence due to impaired glucose tolerance during the TPN support period. However, patients receiving TPN are usually in a critical condition, and there are often other contributing factors affecting blood sugar levels. Further prospective studies to examine the actual applicability and feasibility are warranted. |
本系統中英文摘要資訊取自各篇刊載內容。